BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
9 results:

  • 1. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
    Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
    J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts prognosis and Response to Immunotherapy in Gastric cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
    Shen Y; Gao L; Jiang S; Liu J; Cheng W; Shou H
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):70-75. PubMed ID: 33629514
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium.
    Gonthier C; Trefoux-Bourdet A; Koskas M
    Int J Gynecol Cancer; 2017 Mar; 27(3):493-499. PubMed ID: 28187090
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
    Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
    J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Malnutrition Identified by the Nutritional Risk Index and Poor prognosis in Advanced Epithelial ovarian Carcinoma.
    Yim GW; Eoh KJ; Kim SW; Nam EJ; Kim YT
    Nutr Cancer; 2016 Jul; 68(5):772-9. PubMed ID: 27044606
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
    Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
    Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.